Acadia Pharmaceuticals reported $228.48M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Aptinyx Inc APTX:US $ 19.38M 207K
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Cara Therapeutics CARA:US $ 32.7M 1.64M
Corcept Therapeutics CORT:US $ 66.92M 4.76M
Cytokinetics CYTK:US $ 81.7M 4.39M
Eisai 4523:JP Y 211704M 22380M
Eli Lilly And LLY:US $ 5405.7M 677M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Intra Cellular Therapies ITCI:US $ 107.66M 4.02M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Marinus Pharmaceuticals MRNS:US $ 30.9M 2.26M
Moderna Inc MRNA:US 1.84B 38M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Pfizer PFE:US $ 15788M 3271M
Prothena PRTA:US 39.1M 4.83M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Vanda Pharmaceuticals VNDA:US $ 67.86M 8.48M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
YTE INCY:US $ 616.69M 135.42M